205 related articles for article (PubMed ID: 11381492)
1. Thymosin alpha-1.
Ancell CD; Phipps J; Young L
Am J Health Syst Pharm; 2001 May; 58(10):879-85; quiz 886-8. PubMed ID: 11381492
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled study.
You J; Zhuang L; Cheng HY; Yan SM; Yu L; Huang JH; Tang BZ; Huang ML; Ma YL; Chongsuvivatwong V; Sriplung H; Geater A; Qiao YW; Wu RX
World J Gastroenterol; 2006 Nov; 12(41):6715-21. PubMed ID: 17075991
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial.
Sherman KE; Sjogren M; Creager RL; Damiano MA; Freeman S; Lewey S; Davis D; Root S; Weber FL; Ishak KG; Goodman ZD
Hepatology; 1998 Apr; 27(4):1128-35. PubMed ID: 9537454
[TBL] [Abstract][Full Text] [Related]
4. Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial.
Andreone P; Gramenzi A; Cursaro C; Felline F; Loggi E; D'Errico A; Spinosa M; Lorenzini S; Biselli M; Bernardi M
J Viral Hepat; 2004 Jan; 11(1):69-73. PubMed ID: 14738560
[TBL] [Abstract][Full Text] [Related]
5. A randomized, controlled, clinical study of thymosin alpha-1 versus interferon-alpha in [corrected] patients with chronic hepatitis B lacking HBeAg in China [corrected].
You J; Zhuang L; Cheng HY; Yan SM; Qiao YW; Huang JH; Tang BZ; Ma YL; Wu GB; Qu JY; Wu RX
J Chin Med Assoc; 2005 Feb; 68(2):65-72. PubMed ID: 15759817
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.
Andreone P; Cursaro C; Gramenzi A; Zavagliz C; Rezakovic I; Altomare E; Severini R; Franzone JS; Albano O; Ideo G; Bernardi M; Gasbarrini G
Hepatology; 1996 Oct; 24(4):774-7. PubMed ID: 8855175
[TBL] [Abstract][Full Text] [Related]
7. In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C.
Andreone P; Cursaro C; Gramenzi A; Margotti M; Ferri E; Talarico S; Biselli M; Felline F; Tuthill C; Martins E; Gasbarrini G; Bernardi M
J Viral Hepat; 2001 May; 8(3):194-201. PubMed ID: 11380797
[TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B.
Zavaglia C; Severini R; Tinelli C; Franzone JS; Airoldi A; Tempini S; Bettale G; Ideo G
Dig Dis Sci; 2000 Apr; 45(4):690-6. PubMed ID: 10759236
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection.
Hung CH; Lee CM; Lu SN; Wang JH; Tung HD; Chen CH; Changchien CS
J Gastroenterol Hepatol; 2005 May; 20(5):727-32. PubMed ID: 15853986
[TBL] [Abstract][Full Text] [Related]
10. Combination low-dose lymphoblastoid interferon and thymosin alpha 1 therapy in the treatment of chronic hepatitis B.
Rasi G; Mutchnick MG; Di Virgilio D; Sinibaldi-Vallebona P; Pierimarchi P; Colella F; Favalli C; Garaci E
J Viral Hepat; 1996 Jul; 3(4):191-6. PubMed ID: 8871880
[TBL] [Abstract][Full Text] [Related]
11. Combination thymosin-alpha 1 and interferon-alpha 2b in the treatment of anti-HBe-positive chronic hepatitis B in Turkey.
Saruc M; Yuceyar H; Kucukmetin N; Demir MA; Kandiloglu AR
Hepatogastroenterology; 2002; 49(45):798-802. PubMed ID: 12063993
[TBL] [Abstract][Full Text] [Related]
12. Thymosin-alpha 1, but not interferon-alpha, specifically inhibits anchorage-independent growth of hepatitis B viral transfected HepG2 cells.
Moshier JA; Mutchnick MG; Dosescu J; Holtz TK; Akkary S; Mahakala K; Merline JR; Naylor PH
J Hepatol; 1996 Dec; 25(6):814-20. PubMed ID: 9007707
[TBL] [Abstract][Full Text] [Related]
13. Interferon and thymosin combination therapy in naive patients with chronic hepatitis C: preliminary results.
Moscarella S; Buzzelli G; Romanelli RG; Monti M; Giannini C; Careccia G; Marrocchi EM; Zignego AL
Liver; 1998 Oct; 18(5):366-9. PubMed ID: 9831367
[TBL] [Abstract][Full Text] [Related]
14. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
Niederau C; Strohmeyer G; Heintges T; Peter K; Göpfert E
Hepatogastroenterology; 1998; 45(21):797-804. PubMed ID: 9684137
[TBL] [Abstract][Full Text] [Related]
15. Combination thymosin alpha 1 and lymphoblastoid interferon treatment in chronic hepatitis C.
Rasi G; DiVirgilio D; Mutchnick MG; Colella F; Sinibaldi-Vallebona P; Pierimarchi P; Valli B; Garaci E
Gut; 1996 Nov; 39(5):679-83. PubMed ID: 9026482
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B.
Saruc M; Ozden N; Turkel N; Ayhan S; Hock LM; Tuzcuoglu I; Yuceyar H
J Pharm Sci; 2003 Jul; 92(7):1386-95. PubMed ID: 12820143
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, placebo-controlled, pilot trial of thymosin alpha 1 for the treatment of chronic hepatitis C.
Andreone P; Cursaro C; Gramenzi A; Buzzi A; Covarelli MG; Di Giammarino L; Miniero R; Arienti V; Bernardi M; Gasbarrini G
Liver; 1996 Jun; 16(3):207-10. PubMed ID: 8873009
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: a prospective, multicenter, randomized, open-label study.
Kim BH; Lee YJ; Kim W; Yoon JH; Jung EU; Park SJ; Kim YJ; Lee HS
Scand J Gastroenterol; 2012 Sep; 47(8-9):1048-55. PubMed ID: 22726105
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial.
Iino S; Toyota J; Kumada H; Kiyosawa K; Kakumu S; Sata M; Suzuki H; Martins EB
J Viral Hepat; 2005 May; 12(3):300-6. PubMed ID: 15850471
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of hepatitis B vaccination and interferon-alpha-2b combination therapy versus interferon-alpha-2b monotherapy in children with chronic hepatitis B.
Helvaci M; Kizilgunesler A; Kasirga E; Ozbal E; Kuzu M; Sozen G
J Gastroenterol Hepatol; 2004 Jul; 19(7):785-91. PubMed ID: 15209626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
